Asston Pharmaceuticals Limited (BOM:544445)

India flag India · Delayed Price · Currency is INR
75.40
-8.60 (-10.24%)
At close: Apr 16, 2026
Market Cap641.88M
Revenue (ttm)244.84M +274.5%
Net Income24.58M +132.6%
EPS3.76 +99.4%
Shares Out8.51M
PE Ratio20.04
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume40,000
Average Volume10,450
Open84.00
Previous Close84.00
Day's Range73.01 - 84.00
52-Week Range65.20 - 126.00
Betan/a
RSI46.70
Earnings DateFeb 13, 2026

About Asston Pharmaceuticals

Asston Pharmaceuticals Limited manufactures pharmaceutical products in India, West Africa, South Africa, and Asian countries. The company provides tablets, such as aceclofenac, albendazole, aminophylline, artemether and lumefantrine, ascorbic acid chewable, azithromycin, b-complex, calcium, cholecalciferol with folic acid, cefixime, cetirizine, ciprofloxacin, co-trimoxazole, cyproheptadine, dexamethasone, diclofenac, ferrous sulphate, folic acid, glucose, griseofulvin, levofloxacin, loperamide HCL, losartan potassium, mebendazole, metformin hyd... [Read more]

Industry Pharmaceutical Preparations
Founded 2019
Country India
Stock Exchange Bombay Stock Exchange
Ticker Symbol 544445
Full Company Profile

Financial Performance

In fiscal year 2025, Asston Pharmaceuticals's revenue was 250.39 million, an increase of 60.65% compared to the previous year's 155.86 million. Earnings were 43.25 million, an increase of 217.95%.

Financial Statements